CAPTRUST Financial Advisors’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $12.4K | Buy |
1,670
+425
| +34% | +$3.15K | ﹤0.01% | 2488 |
|
2025
Q1 | $10.7K | Buy |
+1,245
| New | +$10.7K | ﹤0.01% | 2336 |
|
2022
Q3 | – | Sell |
-9
| Closed | -$1K | – | 3275 |
|
2022
Q2 | $1K | Sell |
9
-2
| -18% | -$222 | ﹤0.01% | 4703 |
|
2022
Q1 | $1K | Sell |
11
-3
| -21% | -$273 | ﹤0.01% | 4718 |
|
2021
Q4 | $2K | Sell |
14
-3
| -18% | -$429 | ﹤0.01% | 4426 |
|
2021
Q3 | $4K | Hold |
17
| – | – | ﹤0.01% | 4044 |
|
2021
Q2 | $6K | Hold |
17
| – | – | ﹤0.01% | 3786 |
|
2021
Q1 | $7K | Sell |
17
-63
| -79% | -$25.9K | ﹤0.01% | 3602 |
|
2020
Q4 | $53K | Buy |
+80
| New | +$53K | ﹤0.01% | 1804 |
|